Kohn M, Delord M, Chbat M, Guemriche A, et al. A third anti-SARS-Cov2 mRNA dose does not overcome the pejorative impact of anti-CD20 therapy and/or low immunoglobulin levels in patients with lymphoma or chronic lymphocytic leukemia. Haematologica 2021 Nov 18. doi: 10.3324/haematol.2021.280026.
PMID: 34788987